Systematic review on Chinese herbal medicine induced liver injury

Evidence-based Complementary and Alternative Medicine

Volumn 2016, Issue , 2016, Pages

  Zhang, Peng ^a   Ye, Yongan ^a   Yang, Xianzhao ^a   Jiao, Yuntao ^a  

^a BEIJING UNIVERSITY OF CHINESE MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

HERBACEOUS AGENT;

ANGELICA SINENSIS; CAUSALITY; CHINESE MEDICINE; CLINICAL OUTCOME; COCHRANE LIBRARY; DATA EXTRACTION; FALLOPIA MULTIFLORA; HERBAL MEDICINE; HUMAN; LATENT PERIOD; LIVER TRANSPLANTATION; MEDLINE; NONHUMAN; PATENT; REVIEW; SYSTEMATIC REVIEW; TOXIC HEPATITIS;

EID: 84987875875     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2016/3560812     Document Type: Review

References (55)

1. M. L. Dossett, R. B. Davis, A. J. Lembo, and G. Y. Yeh, "Complementary and alternative medicine use by US adults with gastrointestinal conditions: results from the 2012 National Health Interview Survey, " The American Journal of Gastroenterology, vol. 109, no. 11, pp. 1705-1711, 2014.
2. T.-G. Liu, S.-Q. Xiong, Y. Yan, H. Zhu, and C. Yi, "Use ofChinese herb medicine in cancer patients: a survey in southwestern China, " Evidence-Based Complementary and Alternative Medicine, vol. 2012, Article ID 769042, 5 pages, 2012.
3. H.-K. Shin, S.-J. Jeong, D. S. Huang, B.-K. Kang, and M. S. Lee, "Usage patterns and adverse experiences in traditional Korean medicine: results of a survey in South Korea, " BMC Complementary and Alternative Medicine, vol. 13, article 340, 2013.
4. G. Shumer, S. Warber, S. Motohara et al., "Complementary and alternative medicine use by visitors to rural Japanese family medicine clinics: results fromthe international complementary and alternative medicine survey, " BMC Complementary and Alternative Medicine, vol. 14, no. 1, article 360, 2014.
5. Group of Hepatobiliary Disease of Digestive Disease Branch of ChineseMedical Association, "Amulticenter survey on hospital inpatients with drug-induced acute liver injury in China, " Zhong Hua Xiao Hua Za Zhi, vol. 27, no. 7, pp. 437-440, 2007 (Chinese).
6. Y. Zhou, L. Yang, Z. L. Liao, X. Y. He, Y. Y. Zhou, and H. Guo, "Epidemiology of drug-induced liver injury in China: a systematic analysis of the Chinese literature including 21 789 patients, " European Journal of Gastroenterology and Hepatology, vol. 25, no. 7, pp. 825-829, 2013.
7. R. Teschke, A. Wolff, C. Frenzel, J. Schulze, and A. Eickhoff, "Herbal hepatotoxicity: a tabular compilation of reported cases, " Liver International, vol. 32, no. 10, pp. 1543-1556, 2012.
8. R. Teschke, A. Wolff, C. Frenzel, and J. Schulze, "Review article: herbal hepatotoxicity-an update on traditionalChinese medicine preparations, " Alimentary Pharmacology and Therapeutics, vol. 40, no. 1, pp. 32-50, 2014.
9. R. Teschke, L. Zhang, H. Long et al., "Traditional Chinese Medicine and herbal hepatotoxicity: a tabular compilation of reported cases, " Annals of Hepatology, vol. 14, no. 1, pp. 7-19, 2015.
10. W.-J. Lee, H.-W. Kim, H.-Y. Lee, and C.-G. Son, "Systematic review on herb-induced liver injury in Korea, " Food and Chemical Toxicology, vol. 84, pp. 47-54, 2015.
11. G. Danan and R. Teschke, "RUCAM in drug and herb induced liver injury: the update, " International Journal of Molecular Sciences, vol. 17, no. 1, article 14, 2016.
12. J. P. Higgins and S. Green, Cochrane Handbook for Systematic Reviews of Interventions. Version 5. 1. 0, 2011, http://handbook.cochrane.org/.
13. D. Moher, A. Liberati, J. Tetzlaff, D. G. Altman, and The PRISMA Group, "Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement, " International Journal of Surgery, vol. 8, no. 5, pp. 336-341, 2010.
14. Pharmacopoeia Commission of the Ministry of Health, Pharmacopoeia of The Peoples Republic of China, 1st Div, China Chemical Industry Press, Beijing, China, 2015 (Chinese).
15. X. Li, C. Qu, Q. He et al., "Acute hepatitis induced by a Chinese herbal product Qibao Meiran Wan: a case study, " International Journal of Clinical and Experimental Medicine, vol. 8, no. 7, pp. 11624-11627, 2015.
16. E. Cortez, C. Boulger, and A. Bernard, "Ban TuWan hepatotoxicity, " BMJ Case Reports, vol. 2012, Article ID 006438, 4 pages, 2012.
17. R. Dhanasekaran, V. Owens, and W. Sanchez, "Chinese skullcap in move free arthritis supplement causes drug induced liver injury and pulmonary infiltrates, " Case Reports in Hepatology, vol. 2013, Article ID965092, 4 pages, 2013.
18. K. A. Jung, H. J. Min, S. S. Yoo et al., "Drug-induced liver injury: twenty five cases of acute hepatitis following ingestion of Polygonum multiflorum thunb, " Gut and Liver, vol. 5, no. 4, pp. 493-499, 2011.
19. H. Dong, D. Slain, J. Cheng, W. Ma, and W. Liang, "Eighteen cases of liver injury following ingestion of Polygonum multiflorum, " Complementary Therapies in Medicine, vol. 22, no. 1, pp. 70-74, 2014.
20. L. Viswanathan and A. Patel, "Hepatotoxicity associated with herbal tea containing kelp, " ACG Case Reports Journal, vol. 1, no. 1, pp. 55-57, 2013.
21. L. Yang, A. Aronsohn, J. Hart, and D. Jensen, "Herbal hepatoxicity from Chinese skullcap: a case report, " World Journal of Hepatology, vol. 4, no. 7, pp. 231-233, 2012.
22. H. J. Kim, H. Kim, J. H. Ahn, and H. J. Suk, "Liver injury induced by herbal extracts containing mistletoe and kudzu, " Journal of Alternative and ComplementaryMedicine, vol. 21, no. 3, pp. 180-185, 2015.
23. H. Inoue, S. Yamazaki, M. Shimizu et al., "Liver injury induced by the Japanese herbal drug Kamishoyosan, " Gastroenterology and Hepatology, vol. 7, no. 10, pp. 692-695, 2011.
24. M. Wang, J. T. Qu, B. Dai, and C. L. Mei, "Fructus Xanthii poisoning: a case report and literature review, " Zhong Guo Quan Ke Yi Xue, vol. 16, no. 2, pp. 218-220, 2013 (Chinese).
25. C. Yuan and L. Chen, "Two cases of recurrent jaundice induced by oral use of He-Shou-Wu, " LinChuangHe Li Yong Yao, vol. 10, no. 7, article 78, 2014 (Chinese).
26. A. H. Jiang and L. M. Yang, "One case of liver injury induced by Huang Yao Zi, " Zhong Guo Bao Jian Ying Yang, no. 5, article 3187, 2014 (Chinese).
27. W. L. Zhang, J. W. Ma, and J. Dong, "Case analysis of liver injury induced by Sheng-He-Shou-Wu, " Kong Jun Yi Xue Za Zhi, vol. 2, no. 30, article 121, 2014 (Chinese).
28. M. Yang, H. Y. Rao, and L. Wei, "Drug-induced liver injury: take care of herbal and dietary supplements, " Jian Kang Guan Li, vol. 12, pp. 57-60, 2014 (Chinese).
29. X. F. Ren and J. M. Xu, "A clinical study on cases with traditional chinese medicine induced liver injury, " An Hui Yi Yao, vol. 19, no. 10, pp. 1997-2000, 2015 (Chinese).
30. L. Mao, S. Q. Li, and Z. Q. Liang, "Drug-induced hepatitis due to oral traditional chinese medicine decoction, " Zhong Guo Yi Yao, vol. 1, no. 8, pp. 121-122, 2013 (Chinese).
31. G. H. Wei, "Liver injury caused by traditional chinesemedicine for psoriasis, " Jian Kang Bi Du ZaZhi, vol. 2, article 163, 2011 (Chinese).
32. J. Ma, L. Zheng, Y.-S. He, and H.-J. Li, "Hepatotoxic assessment of Polygoni Multiflori Radix extract and toxicokinetic study of stilbene glucoside and anthraquinones in rats, " Journal of Ethnopharmacology, vol. 162, pp. 61-68, 2015.
33. G. P. Lv, L. Z. Meng, D. Q. Han, H. Y. Li, J. Zhao, and S. P. Li, "Effect of sample preparation on components and liver toxicity of Polygonum multiflorum, " Journal of Pharmaceutical and Biomedical Analysis, vol. 109, pp. 105-111, 2015.
34. Y. Wang, T. Han, L.-M. Xue et al., "Hepatotoxicity of kaurene glycosides from Xanthium strumarium L. fruits in mice, " Pharmazie, vol. 66, no. 6, pp. 445-449, 2011.
35. J. Wang, L. Ji, H. Liu, and Z. Wang, "Study of the hepatotoxicity induced by Dioscorea bulbifera L. rhizome in mice, " BioScience Trends, vol. 4, no. 2, pp. 79-85, 2010.
36. X.-X. Li, F.-Y. Du, H.-X. Liu, J.-B. Ji, and J. Xing, "Investigation of the active components in Tripterygium wilfordii leading to its acute hepatotoxicty and nephrotoxicity, " Journal of Ethnopharmacology, vol. 162, pp. 238-243, 2015.
37. J. Li, F. Shen, C. Guan et al., "Activation of Nrf2 protects against triptolide-induced hepatotoxicity, " PLoS ONE, vol. 9, no. 7, Article ID e100685, 2014.
38. N. P. Chalasani, P. H. Hayashi, H. L. Bonkovsky, V. J. Navarro, W. M. Lee, and R. J. Fontana, "ACGclinical guideline: the diagnosis and management of idiosyncratic drug-induced liver injury, " The American Journal of Gastroenterology, vol. 109, no. 7, pp. 950-966, 2014.
39. W. M. Lee, R. H. Squires Jr., S. L. Nyberg, E. Doo, and J. H. Hoofnagle, "Acute liver failure: summary of a workshop, " Hepatology, vol. 47, no. 4, pp. 1401-1415, 2008.
40. A. Reuben, D. G. Koch, and W. M. Lee, "Drug-induced acute liver failure: results of a U. S. multicenter, prospective study, " Hepatology, vol. 52, no. 6, pp. 2065-2076, 2010.
41. S. H. Bae, D. H. Kim, Y. S. Bae et al., "Toxic hepatitis associated with Polygoni multiflori, " The Korean Journal of Hepatology, vol. 16, no. 2, pp. 182-186, 2010.
42. P. Ou, Y. Chen, B. Li et al., "Causes, clinical features and outcomes of drug-induced liver injury in hospitalized patients in a Chinese tertiary care hospital, " SpringerPlus, vol. 4, article 802, 2015.
43. G. P. Lv, L. Z. Meng, D. Q. Han, H. Y. Li, J. Zhao, and S. P. Li, "Effect of sample preparation on components and liver toxicity of Polygonum multiflorum, " Journal of Pharmaceutical and Biomedical Analysis, vol. 109, pp. 105-111, 2015.
44. W. I. Cheung, M. L. Tse, T. Ngan et al., "Liver injury associated with the use of Fructus Psoraleae (Bol-gol-zhee or Bu-gu-zhi) and its related proprietary medicine, " Clinical Toxicology, vol. 47, no. 7, pp. 683-685, 2009.
45. K. Wang, Z. Song, H. Wang, Q. Li, Z. Cui, and Y. Zhang, "Angelica sinensis polysaccharide attenuates concanavalin A-induced liver injury in mice, " International Immunopharmacology, vol. 31, pp. 140-148, 2016.
46. Y.-M. Liu, L.-L. Zhu, R. Li et al., "Xijiao Dihuang Decoction (fbft) and Rehmannia glutinosa Libosch. protect mice against lipopolysaccharide and tumor necrosis factor alpha-induced acute liver failure, " Chinese Journal of IntegrativeMedicine, 2015.
47. S. Wu, Y. Yue, H. Tian et al., "Carthamus red fromCarthamus tinctorius L. exerts antioxidant and hepatoprotective effect againstCCl4-inducedliver damage in rats via theNrf2pathway, " Journal of Ethnopharmacology, vol. 148, no. 2, pp. 570-578, 2013.
48. B. Zhang, Q. Zhang, M. Liu et al., "Increased involvement of Panax notoginseng in the mechanism of decreased hepatotoxicity induced by Tripterygium wilfordii in rats, " Journal of Ethnopharmacology, vol. 185, pp. 243-254, 2016.
49. Livertox, Chinese and Other Asian Herbal Medicines. 2016 http://livertox.nih.gov/.
50. Hepatox, http://www.hepatox.org/chPatentDrug.
51. J. Rochon, P. Protiva, L. B. Seeff et al., "Reliability of theRoussel Uclaf Causality Assessment Method for assessing causality in drug-induced liver injury, " Hepatology, vol. 48, no. 4, pp. 1175-1183, 2008.
52. R. Teschke, C. Frenzel, J. Schulze, and A. Eickhoff, "Herbal hepatotoxicity: challenges and pitfalls of causality assessment methods, " World Journal of Gastroenterology, vol. 19, no. 19, pp. 2864-2882, 2013.
53. R. Teschke, A. Wolff, C. Frenzel, A. Schwarzenboeck, J. Schulze, and A. Eickhoff, "Drug and herb induced liver injury: council for International Organizations of Medical Sciences scale for causality assessment, " World Journal of Hepatology, vol. 6, no. 1, pp. 17-32, 2014.
54. R. Teschke, A. Eickhoff, and J. Schulze, "Drug- and herbinduced liver injury in clinical and translational hepatology: causality assessment methods, quo vadis?" Journal of Clinical and Translational Hepatology, vol. 1, no. 1, pp. 59-74, 2013.
55. T. Tran and W. M. Lee, "DILI: new insights into diagnosis and management, " CurrentHepatitis Reports, vol. 12, no. 1, pp. 53-58, 2013.